Cellyan Biotechnology Co., Ltd (HKPD)

NASDAQ: HKPD · Real-Time Price · USD

0.6498

-0.0182 (-2.72%)

At close: Mar 6, 2026, 4:00 PM EST

0.6103

-0.0395 (-6.09%)

After-hours: Mar 6, 2026, 5:39 PM EST

Cellyan Biotechnology Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023
Net Income	-0.03	1.33	1
Depreciation & Amortization	1.07	0.93	0.71
Other Adjustments	0.04	-0	-
Change in Receivables	-0.92	-2.05	-0.93
Changes in Inventories	0.38	-0.74	-0.19
Changes in Accounts Payable	0.4	-0.11	0.96
Changes in Income Taxes Payable	-0.11	0.2	0.02
Changes in Unearned Revenue	-0.07	-0.08	0.21
Changes in Other Operating Activities	-0.19	0.13	-0.05
Operating Cash Flow	0.57	-0.39	1.73
Capital Expenditures	-0.07	-0.05	-0.11
Sale of Property, Plant & Equipment	-	0.03	-
Purchases of Intangible Assets	-0.09	-0.04	-0
Purchases of Investments	-2.3	-	-
Other Investing Activities	-	0.01	-0.01
Investing Cash Flow	-2.45	-0.04	-0.13
Long-Term Debt Issued	0.77	1.37	-
Long-Term Debt Repaid	-0.24	-0.22	-0.08
Net Long-Term Debt Issued (Repaid)	0.53	1.15	-0.08
Issuance of Common Stock	4.3	0.51	-
Net Common Stock Issued (Repurchased)	4.3	0.51	-
Other Financing Activities	-2.84	-1.13	-1.07
Financing Cash Flow	2	0.54	-1.16
Effect of Exchange Rate Changes on Cash and Cash Equivalents	0.01	0	0
Net Cash Flow	0.12	0.1	0.44
Free Cash Flow	0.5	-0.45	1.61
FCF Margin	2.46%	-2.68%	12.84%
Free Cash Flow Per Share	0.05	-0.05	0.24
Levered Free Cash Flow	1.91	2.76	2.46
Unlevered Free Cash Flow	-25.52	24.56	21.76

Updated Mar 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q